(Q38062882)

28 August 2017

1 reference

title

Methodological lessons from clinical trials and the future of microbicide research (English)

1 reference

28 August 2017

author

Ariane van der Straten

series ordinal

1

object named as

Ariane van der Straten

1 reference

28 August 2017

4

Alexandra Minnis

1 reference

28 August 2017

Elizabeth T Montgomery

series ordinal

2

object named as

Elizabeth T Montgomery

1 reference

28 August 2017

Miriam Hartmann

3

1 reference

28 August 2017

publication date

1 March 2013

1 reference

28 August 2017

published in

Current HIV/AIDS reports

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

89-102

1 reference

Topical prophylaxis for HIV prevention in women: becoming a reality

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Open access for the non-English-speaking world: overcoming the language barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Preexposure prophylaxis for HIV infection among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

State of the science of adherence in pre-exposure prophylaxis and microbicide trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Predicting product adherence in a topical microbicide safety trial in Pune, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Patient adherence to prescribed antimicrobial drug dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A proposal for quality standards for measuring medication adherence in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Optimal recall period and response task for self-reported HIV medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Evaluation of microbicide gel adherence monitoring methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Validation of a dye stain assay for vaginally inserted hydroxyethylcellulose-filled microbicide applicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Feasibility of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

The meaning of adherence when behavioral risk patterns vary: obscured use- and method-effectiveness in HIV-prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Vaginal practices, microbicides and HIV: what do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Vaginal practices as women's agency in sub-Saharan Africa: a synthesis of meaning and motivation through meta-ethnography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Developmental validation of RSID™-Semen: a lateral flow immunochromatographic strip test for the forensic detection of human semen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

HIV prevention research: accomplishments and challenges for the third decade of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Randomised controlled trial on whether advance knowledge of prostate-specific antigen testing improves participant reporting of unprotected sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Medication compliance--helping patients through technology: modern "smart" pillboxes keep memory-short patients on their medical regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0141-9

Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies

21 January 2018

1 reference

12 December 2020

Condom use and vaginal Y-chromosome detection: the specificity of a potential biomarker

1 reference

12 December 2020

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

12 December 2020

Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa

1 reference

12 December 2020

Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania

1 reference

12 December 2020

Early clinical experience with networked system for promoting patient self-management

1 reference

12 December 2020

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate

1 reference

12 December 2020

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection

1 reference

12 December 2020

Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials

1 reference

12 December 2020

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials

1 reference

12 December 2020

Persisting with prevention: the importance of adherence for HIV prevention

1 reference

12 December 2020

State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.

1 reference

12 December 2020

"Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study

1 reference

12 December 2020

10.1007/S11904-012-0141-9

Identifiers

DOI

1 reference

28 August 2017

1 reference